Transcriptional activation of human GM3 synthase (hST3Gal V) gene by valproic acid in ARPE-19 human retinal pigment epithelial cells

BMB Rep. 2011 Jun;44(6):405-9. doi: 10.5483/BMBRep.2011.44.6.405.

Abstract

The present study demonstrated that valproic acid (VPA) transcriptionally regulates human GM3 synthase (hST3Gal V), which catalyzes ganglioside GM3 biosynthesis in ARPE-19 human retinal pigment epithelial cells. For this, we characterized the promoter region of the hST3Gal V gene. Functional analysis of the 5'-flanking region of the hST3Gal V gene revealed that the -177 to -83 region functions as the VPA-inducible promoter and that the CREB/ATF binding site at -143 is crucial for VPA-induced expression of hST3Gal V in ARPE-19 cells. In addition, the transcriptional activity of hST3Gal V induced by VPA in ARPE-19 cells was inhibited by SP600125, a c-Jun N-terminal kinase (JNK) inhibitor. In summary, our results identified the core promoter region in the hST3Gal V promoter and for the first time demonstrated that ATF2 binding to the CREB/ATF binding site at -143 is essential for transcriptional activation of hST3Gal V in VPA-induced ARPE-19 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 2 / genetics
  • Activating Transcription Factor 2 / metabolism
  • Animals
  • Binding Sites
  • Cell Line
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects*
  • Epithelial Cells / physiology*
  • Gene Expression Regulation, Enzymologic / drug effects
  • Humans
  • JNK Mitogen-Activated Protein Kinases / genetics
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Promoter Regions, Genetic
  • Retinal Pigment Epithelium / cytology*
  • Sialyltransferases / genetics
  • Sialyltransferases / metabolism*
  • Signal Transduction / physiology
  • Transcriptional Activation / drug effects*
  • Valproic Acid / pharmacology*

Substances

  • ATF2 protein, human
  • Activating Transcription Factor 2
  • Enzyme Inhibitors
  • Valproic Acid
  • Sialyltransferases
  • haematoside synthetase
  • JNK Mitogen-Activated Protein Kinases